Document is current
Any future updates will be listed below
-
Authors
Kumar, Aditi
Galbraith, Niall
Al-Hassi, Hafid O.
Jain, Manushri
Phipps, Oliver
Butterworth, Jeffrey
Steed, Helen
McLaughlin, John
Brookes, Matthew J.
-
Funding
Funding for this research was provided by:
Bowel and Cancer Research
Tillotts Pharma
- License Information
-
More Information
Article History
Received: 21 December 2021
Accepted: 9 June 2022
First Online: 2 July 2022
Declarations
:
: Ethical approval was granted for this study by the London-Stanmore Research Ethics Committee, UK and the trial was conducted in accordance with ICH GCP (Ethical approval REC Ref: 16/LO/1325). The study was undertaken in line with the declaration of Helsinki 1964, amended at Edinburgh in 2000. We obtained written informed consent from all study participants.
: Not applicable.
: MJB has received grants and travel expenses from Vifor International and Tillotts Pharma, outside of the submitted work. The research department of MJB also received funding from Tillotts Pharma to support part of the described work. HS has received travel and conference expenses from Tillotts Pharma, Norgine, MSD, Abbvie and Janssen outside of the submitted work. NG has received funds from Tillotts Pharma outside of the submitted work. AK, HOA, MJ, OP, JB, JM have no competing interests.
